JP2007506430A - 耐熱性酵素を使用するポリヌクレオチド合成方法 - Google Patents
耐熱性酵素を使用するポリヌクレオチド合成方法 Download PDFInfo
- Publication number
- JP2007506430A JP2007506430A JP2006528170A JP2006528170A JP2007506430A JP 2007506430 A JP2007506430 A JP 2007506430A JP 2006528170 A JP2006528170 A JP 2006528170A JP 2006528170 A JP2006528170 A JP 2006528170A JP 2007506430 A JP2007506430 A JP 2007506430A
- Authority
- JP
- Japan
- Prior art keywords
- cell
- polynucleotide
- kit
- cloning vector
- reaction mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 74
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 74
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 74
- 102000004190 Enzymes Human genes 0.000 title description 21
- 108090000790 Enzymes Proteins 0.000 title description 21
- 238000001308 synthesis method Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 45
- 239000011541 reaction mixture Substances 0.000 claims abstract description 30
- 230000000295 complement effect Effects 0.000 claims abstract description 12
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 88
- 241000588724 Escherichia coli Species 0.000 claims description 21
- 239000013599 cloning vector Substances 0.000 claims description 20
- 108091008146 restriction endonucleases Proteins 0.000 claims description 13
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 9
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 9
- 239000011535 reaction buffer Substances 0.000 claims description 8
- 238000005382 thermal cycling Methods 0.000 claims description 8
- 241000589500 Thermus aquaticus Species 0.000 claims description 7
- 238000010367 cloning Methods 0.000 claims description 7
- 239000005547 deoxyribonucleotide Substances 0.000 claims description 7
- 125000002637 deoxyribonucleotide group Chemical group 0.000 claims description 7
- 108090000133 DNA helicases Proteins 0.000 claims description 6
- 102100031780 Endonuclease Human genes 0.000 claims description 6
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 6
- 102000003844 DNA helicases Human genes 0.000 claims description 5
- 108091028664 Ribonucleotide Proteins 0.000 claims description 4
- 241000589499 Thermus thermophilus Species 0.000 claims description 4
- 239000005546 dideoxynucleotide Substances 0.000 claims description 4
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 4
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 4
- 239000002336 ribonucleotide Substances 0.000 claims description 4
- 125000002652 ribonucleotide group Chemical group 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 3
- 210000004962 mammalian cell Anatomy 0.000 claims description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 102000003960 Ligases Human genes 0.000 claims description 2
- 241000205156 Pyrococcus furiosus Species 0.000 claims description 2
- 241000205180 Thermococcus litoralis Species 0.000 claims description 2
- 241000589498 Thermus filiformis Species 0.000 claims description 2
- 210000005253 yeast cell Anatomy 0.000 claims description 2
- 241000205160 Pyrococcus Species 0.000 claims 1
- 241000204666 Thermotoga maritima Species 0.000 claims 1
- 239000013612 plasmid Substances 0.000 description 38
- 239000013615 primer Substances 0.000 description 29
- 239000002987 primer (paints) Substances 0.000 description 29
- 230000003321 amplification Effects 0.000 description 27
- 238000003199 nucleic acid amplification method Methods 0.000 description 27
- 230000001580 bacterial effect Effects 0.000 description 23
- 229940088598 enzyme Drugs 0.000 description 20
- 239000002299 complementary DNA Substances 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 18
- 239000013598 vector Substances 0.000 description 16
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 12
- 239000000872 buffer Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 108010006785 Taq Polymerase Proteins 0.000 description 9
- 239000011543 agarose gel Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000002773 nucleotide Substances 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 5
- 239000013504 Triton X-100 Substances 0.000 description 5
- 229920004890 Triton X-100 Polymers 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 108010077805 Bacterial Proteins Proteins 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 101150066555 lacZ gene Proteins 0.000 description 4
- 239000001226 triphosphate Substances 0.000 description 4
- 235000011178 triphosphate Nutrition 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 101000925646 Enterobacteria phage T4 Endolysin Proteins 0.000 description 3
- 241000701533 Escherichia virus T4 Species 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 239000005332 obsidian Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 101150017040 I gene Proteins 0.000 description 1
- 101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000205192 Pyrococcus woesei Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000204652 Thermotoga Species 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- -1 nucleotide triphosphates Chemical class 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000009305 pseudorabies Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50530003P | 2003-09-23 | 2003-09-23 | |
| PCT/US2004/031267 WO2005030995A1 (en) | 2003-09-23 | 2004-09-23 | Methods of synthesizing polynucleotides using thermostable enzymes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007506430A true JP2007506430A (ja) | 2007-03-22 |
| JP2007506430A5 JP2007506430A5 (https=) | 2007-11-15 |
Family
ID=34393006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006528170A Abandoned JP2007506430A (ja) | 2003-09-23 | 2004-09-23 | 耐熱性酵素を使用するポリヌクレオチド合成方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20050064490A1 (https=) |
| EP (1) | EP1664347A1 (https=) |
| JP (1) | JP2007506430A (https=) |
| CN (1) | CN1856579A (https=) |
| AU (1) | AU2004276790A1 (https=) |
| CA (1) | CA2535922A1 (https=) |
| WO (1) | WO2005030995A1 (https=) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8286665B2 (en) | 2006-03-22 | 2012-10-16 | The Regents Of The University Of California | Multiplexed latching valves for microfluidic devices and processors |
| US8388908B2 (en) | 2009-06-02 | 2013-03-05 | Integenx Inc. | Fluidic devices with diaphragm valves |
| US8420318B2 (en) | 2004-06-01 | 2013-04-16 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
| US8431390B2 (en) | 2004-09-15 | 2013-04-30 | Integenx Inc. | Systems of sample processing having a macro-micro interface |
| US8454906B2 (en) | 2007-07-24 | 2013-06-04 | The Regents Of The University Of California | Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions |
| US8476063B2 (en) | 2004-09-15 | 2013-07-02 | Integenx Inc. | Microfluidic devices |
| US8512538B2 (en) | 2010-05-28 | 2013-08-20 | Integenx Inc. | Capillary electrophoresis device |
| US8557518B2 (en) | 2007-02-05 | 2013-10-15 | Integenx Inc. | Microfluidic and nanofluidic devices, systems, and applications |
| US8584703B2 (en) | 2009-12-01 | 2013-11-19 | Integenx Inc. | Device with diaphragm valve |
| US8672532B2 (en) | 2008-12-31 | 2014-03-18 | Integenx Inc. | Microfluidic methods |
| US8748165B2 (en) | 2008-01-22 | 2014-06-10 | Integenx Inc. | Methods for generating short tandem repeat (STR) profiles |
| US8763642B2 (en) | 2010-08-20 | 2014-07-01 | Integenx Inc. | Microfluidic devices with mechanically-sealed diaphragm valves |
| US8841116B2 (en) | 2006-10-25 | 2014-09-23 | The Regents Of The University Of California | Inline-injection microdevice and microfabricated integrated DNA analysis system using same |
| US9121058B2 (en) | 2010-08-20 | 2015-09-01 | Integenx Inc. | Linear valve arrays |
| US9644623B2 (en) | 2002-12-30 | 2017-05-09 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
| JP2019510504A (ja) * | 2016-04-06 | 2019-04-18 | グリーンライト バイオサイエンシーズ インコーポレーテッドＧｒｅｅｎｌｉｇｈｔ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． | リボ核酸の無細胞的生産 |
| US11274284B2 (en) | 2015-03-30 | 2022-03-15 | Greenlight Biosciences, Inc. | Cell-free production of ribonucleic acid |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8685648B2 (en) * | 2009-02-03 | 2014-04-01 | Biohelix Corporation | Endonuclease-enhanced helicase-dependent amplification |
| EP2611922A1 (en) | 2010-08-31 | 2013-07-10 | Greenlight Biosciences, Inc. | Methods for control of flux in metabolic pathways through protease manipulation |
| AU2014306074B2 (en) | 2013-08-05 | 2018-08-30 | Greenlight Biosciences, Inc. | Engineered proteins with a protease cleavage site |
| EP3430154B1 (en) * | 2016-03-14 | 2020-11-11 | Rgene, Inc. | Hyper-thermostable lysine-mutant ssdna/rna ligases |
| EP3565892A4 (en) | 2017-01-06 | 2020-10-07 | Greenlight Biosciences, Inc. | Cell-free production of sugars |
| KR102894284B1 (ko) | 2017-10-11 | 2025-12-03 | 그린라이트 바이오사이언시스, 아이엔씨. | 뉴클레오시드 트리포스페이트 및 리보핵산 생산을 위한 방법 및 조성물 |
| CN114990080B (zh) * | 2021-07-01 | 2023-07-21 | 温州医科大学 | 一种赖氨酸突变的热稳定核酸连接酶 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374553A (en) * | 1986-08-22 | 1994-12-20 | Hoffmann-La Roche Inc. | DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima |
| US5283173A (en) * | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5352778A (en) * | 1990-04-26 | 1994-10-04 | New England Biolabs, Inc. | Recombinant thermostable DNA polymerase from archaebacteria |
| US5756334A (en) * | 1990-04-26 | 1998-05-26 | New England Biolabs, Inc. | Thermostable DNA polymerase from 9°N-7 and methods for producing the same |
| CA2092317A1 (en) * | 1990-09-28 | 1992-03-29 | David H. Gelfand | Purified thermostable nucleic acid polymerase enzyme from thermosipho africanus |
| AU664050B2 (en) * | 1991-12-18 | 1995-11-02 | Becton Dickinson & Company | Process for lysing mycobacteria |
| CA2159081C (en) * | 1993-03-24 | 2000-11-21 | David Mead | Dinucleotide restriction endonuclease preparations and methods of use |
| US6100078A (en) * | 1994-04-01 | 2000-08-08 | Gen-Probe Incorporated | Purified DNA polymerase from bacillus stearothermophilus ATCC 12980 |
| US6306588B1 (en) * | 1997-02-07 | 2001-10-23 | Invitrogen Corporation | Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof |
| DE69836482T2 (de) * | 1997-07-25 | 2007-09-27 | Agene Research Institute, Co., Ltd., Kamakura | Menschliches recq4 gen, das für eine helikase kodiert |
| US20010018192A1 (en) * | 1998-02-12 | 2001-08-30 | Terstappen Leon W.M.M. | Labeled cells for use as an internal functional control in rare cell detection assays |
| EP1127135B1 (en) * | 1998-10-30 | 2007-05-23 | Cornell Research Foundation, Inc. | High fidelity thermostable ligase and uses thereof |
| US6436677B1 (en) * | 2000-03-02 | 2002-08-20 | Promega Corporation | Method of reverse transcription |
| US6323009B1 (en) * | 2000-06-28 | 2001-11-27 | Molecular Staging, Inc. | Multiply-primed amplification of nucleic acid sequences |
| EP1301205A1 (en) * | 2000-07-12 | 2003-04-16 | Invitrogen Corporation | High fidelity polymerases and uses thereof |
-
2004
- 2004-09-23 WO PCT/US2004/031267 patent/WO2005030995A1/en not_active Ceased
- 2004-09-23 AU AU2004276790A patent/AU2004276790A1/en not_active Abandoned
- 2004-09-23 JP JP2006528170A patent/JP2007506430A/ja not_active Abandoned
- 2004-09-23 CN CNA2004800274720A patent/CN1856579A/zh active Pending
- 2004-09-23 CA CA002535922A patent/CA2535922A1/en not_active Abandoned
- 2004-09-23 EP EP04784918A patent/EP1664347A1/en not_active Withdrawn
- 2004-09-23 US US10/947,832 patent/US20050064490A1/en not_active Abandoned
-
2006
- 2006-06-26 US US11/426,422 patent/US20060252083A1/en not_active Abandoned
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9651039B2 (en) | 2002-12-30 | 2017-05-16 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
| US9644623B2 (en) | 2002-12-30 | 2017-05-09 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
| US8420318B2 (en) | 2004-06-01 | 2013-04-16 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
| US9752185B2 (en) | 2004-09-15 | 2017-09-05 | Integenx Inc. | Microfluidic devices |
| US8431390B2 (en) | 2004-09-15 | 2013-04-30 | Integenx Inc. | Systems of sample processing having a macro-micro interface |
| US8431340B2 (en) | 2004-09-15 | 2013-04-30 | Integenx Inc. | Methods for processing and analyzing nucleic acid samples |
| US8476063B2 (en) | 2004-09-15 | 2013-07-02 | Integenx Inc. | Microfluidic devices |
| US8551714B2 (en) | 2004-09-15 | 2013-10-08 | Integenx Inc. | Microfluidic devices |
| US8286665B2 (en) | 2006-03-22 | 2012-10-16 | The Regents Of The University Of California | Multiplexed latching valves for microfluidic devices and processors |
| US8841116B2 (en) | 2006-10-25 | 2014-09-23 | The Regents Of The University Of California | Inline-injection microdevice and microfabricated integrated DNA analysis system using same |
| US8557518B2 (en) | 2007-02-05 | 2013-10-15 | Integenx Inc. | Microfluidic and nanofluidic devices, systems, and applications |
| US8454906B2 (en) | 2007-07-24 | 2013-06-04 | The Regents Of The University Of California | Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions |
| US8748165B2 (en) | 2008-01-22 | 2014-06-10 | Integenx Inc. | Methods for generating short tandem repeat (STR) profiles |
| US8672532B2 (en) | 2008-12-31 | 2014-03-18 | Integenx Inc. | Microfluidic methods |
| US8388908B2 (en) | 2009-06-02 | 2013-03-05 | Integenx Inc. | Fluidic devices with diaphragm valves |
| US8584703B2 (en) | 2009-12-01 | 2013-11-19 | Integenx Inc. | Device with diaphragm valve |
| US8512538B2 (en) | 2010-05-28 | 2013-08-20 | Integenx Inc. | Capillary electrophoresis device |
| US8763642B2 (en) | 2010-08-20 | 2014-07-01 | Integenx Inc. | Microfluidic devices with mechanically-sealed diaphragm valves |
| US9121058B2 (en) | 2010-08-20 | 2015-09-01 | Integenx Inc. | Linear valve arrays |
| US9731266B2 (en) | 2010-08-20 | 2017-08-15 | Integenx Inc. | Linear valve arrays |
| US11274284B2 (en) | 2015-03-30 | 2022-03-15 | Greenlight Biosciences, Inc. | Cell-free production of ribonucleic acid |
| JP2019510504A (ja) * | 2016-04-06 | 2019-04-18 | グリーンライト バイオサイエンシーズ インコーポレーテッドＧｒｅｅｎｌｉｇｈｔ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． | リボ核酸の無細胞的生産 |
| JP7011599B2 (ja) | 2016-04-06 | 2022-02-10 | グリーンライト バイオサイエンシーズ インコーポレーテッド | リボ核酸の無細胞的生産 |
| JP2022062056A (ja) * | 2016-04-06 | 2022-04-19 | グリーンライト バイオサイエンシーズ インコーポレーテッド | リボ核酸の無細胞的生産 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20050064490A1 (en) | 2005-03-24 |
| WO2005030995A1 (en) | 2005-04-07 |
| US20060252083A1 (en) | 2006-11-09 |
| CN1856579A (zh) | 2006-11-01 |
| CA2535922A1 (en) | 2005-04-07 |
| EP1664347A1 (en) | 2006-06-07 |
| AU2004276790A1 (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007506430A (ja) | 耐熱性酵素を使用するポリヌクレオチド合成方法 | |
| US5928905A (en) | End-complementary polymerase reaction | |
| RU2260055C2 (ru) | Способ амплификации днк и композиция для его осуществления | |
| US6274353B1 (en) | Method and compositions for improved polynucleotide synthesis | |
| CA2417798A1 (en) | Method of amplifying nucleic acid | |
| JP6579204B2 (ja) | 改変された耐熱性ｄｎａポリメラーゼ | |
| JP2003535587A (ja) | 低温感受性変異体ｄｎａポリメラーゼ | |
| CN114561374B (zh) | 一种嗜热核酸内切酶突变体及其制备方法和应用 | |
| JP2003525627A (ja) | 増加した熱安定性を有するｒｎａポリメラーゼ変異体 | |
| CN112921015A (zh) | 高特异性Taq DNA聚合酶变体及其在基因组编辑和基因突变检测中的应用 | |
| JP2009520461A (ja) | Ｓｓｂ−ポリメラーゼ融合タンパク質 | |
| WO2000032763A1 (en) | METHOD FOR SYNTHESIZING cDNA | |
| Nakano et al. | Single-step single-molecule PCR of DNA with a homo-priming sequence using a single primer and hot-startable DNA polymerase | |
| JP2002506626A (ja) | Ｔｈｅｍｏａｎａｅｒｏｂａｃｔｅｒｔｈｅｒｍｏｈｙｄｒｏｓｕｌｆｒｉｃｕｓ由来の熱安定性ＤＮＡポリメラーゼ | |
| US7148339B2 (en) | Temperature sensitive mutant of bacteriophage T4 endonuclease VII | |
| JP3891330B2 (ja) | 改変された耐熱性ｄｎａポリメラーゼ | |
| AU2001286268B2 (en) | Method of forming complex | |
| WO2024244010A1 (zh) | 用于测序的dna聚合酶突变体 | |
| CN113684194A (zh) | 一种突变的马达蛋白及其应用、试剂盒 | |
| US20040002155A1 (en) | Endonuclease VII cloning method | |
| CN113528624A (zh) | 扩增和检测核酸的方法及试剂盒 | |
| Penalva et al. | An optimized procedure to mutagenize long (> 10 kb) plasmids by PCR | |
| Anisimova et al. | Effect of Recombinant Protein ttRecA on Specificity, Efficiency and Accuracy of Taq DNA Polymerase in PCR | |
| Coffin | HSV Mutagenesis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070925 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070925 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20100625 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100625 |